Publication | Closed Access
Neoadjuvant chemoradiotherapy for clinical stage II-III esophageal squamous cell carcinoma.
20
Citations
12
References
2011
Year
A pathological complete response to NACRT is critical for improving the survival of patients with clinical stageII-III ESCC.
| Year | Citations | |
|---|---|---|
Page 1
Page 1